What this study is
The researchers want to learn how androgens, a type of sex hormone, might affect nonalcoholic fatty liver (NAFLD) in young women over time. NAFLD happens when fat builds up in the liver which can cause damage to the liver such as inflammation or scarring.
Young women with a condition called polycystic ovary syndrome (PCOS) have a high risk for NAFLD, and they often have high androgen levels too. So the researchers are recruiting young women with PCOS as well as those without PCOS, and will compare changes in NAFLD over time between young women with and without PCOS.
This study is funded by the National Institutes of Health
Study details
- Official title
- Androgens and Nonalcoholic Fatty Liver Disease (NAFLD) In Reproductive-Aged Women With and Without Polycystic Ovary Syndrome (PCOS)
- Sponsor
- University of California, San Francisco
- Conditions
- PCOS · NAFLD · NASH
- Enrolling
- 150 people
- Starts
- 2024-01-22
- Est. completion
- 2028-12
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years – 42 YearsSex FEMALEHealthy volunteers Not acceptedYou may qualify if
- Metabolic associated steatohepatitis (MASH) (formerly NASH)
- PCOS
- Non-PCOS
You can't join if
- High levels of alcohol use (more than 7 drinks a week)
- Current pregnancy
- Other causes of hepatic steatosis
- Weight loss of more than 10% body weight in the last 6 months
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (2)
2 openUniversity of California San Francisco
San Francisco, California, United States
- Elle K Oberweis-Manion, B.A. · Contact415-502-3725elle.oberweismanion@ucsf.edu
- Jasmine Gamez, B.S. · Contact415-353-9240jasmine.gamez@ucsf.edu
RecruitingDuke University
Durham, North Carolina, United States
- Linda Perry, R.N. · Contactlinda.blalock@duke.edu
Not yet recruiting
Study team
Sponsor
University of California, San Francisco
Study ID 23-39040
Principal investigator
Monika A Sarkar, M.D., M.A.S
University of California, San Francisco
Principal investigator
Ayako Suzuki, M.D.,Ph.D.
Duke University
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.